Health/Disease Strategy

Patients faced with high out-of-pocket costs sometimes delay seeking care for appendicitis or diverticulitis, which can result in higher overall costs, increased risk of mortality, and a worse quality of life.

Paying attention to the social determinants of health may be a powerful way of improving cardiovascular outcomes.

Diabetes education has shifted from in-person classes to Zoom meetings.

Guidelines to prevent retinopathy caused by a drug to treat autoimmune disease must be developed jointly by ophthalmologists and prescribing physicians, journal authors say.

How real-world evidence will help FDA develop a vaccine.

FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.

A new study has surprising findings about the cost effectiveness of continuous glucose monitoring for type 1 diabetes patients.

How would the FDA proposal to reduce the amount of salt in people’s diets affect healthcare costs? Find out.

How skipping industry acronyms and jargon and using simple terminology will eliminate confusion and misinterpretation.

A Surescripts survey reveals the need for more interoperable access to patient data in three major areas.

The conditions that are the biggest drivers of female mortality, some preventive measures, and the latest treatment advances.

There’s surprising findings in Numerof & Associates’ study about healthcare executives’ population health management objectives.

A Ball State University study has astonishing findings about racial and ethnic minorities and their participation in health-related research.

Apple brings health records to the iPhone. Find out what it means for EHR interoperability and patient engagement.

A call center-based social support role may be a valuable addition to the evolving healthcare workforce, according to a new study.

How Humana is successfully improving care for members in two cities.

Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.

Healthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.

Experts weigh in on the spending outlook for these high-cost conditions.

Gene therapy is leaving its mark, while payers contemplate payment models, value, and efficacy issues.

A UCLA study shows that the Great Recession intensified patients’ cardiovascular risk factors.

Reduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.

Unfortunately, the issue for many vets who experience trauma is that the mental health services they need are too far away from home. Here’s one solution.

Genetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.

Switzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.

Treatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.

The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.

From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.

CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know

Pending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.